BCEIE › News › TATACHEM

Results

Tata Chemicals: The financial results for the period ended September 30, 2026

Tata Chemicals (TATACHEM) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹15,475 crore.

BCEIE News Desk · Published 7 Nov 2026, 05:27 pm IST · Filing received 7 Nov 2026, 05:10 pm IST

What happened

Tata Chemicals (TATACHEM) filed a disclosure with the exchanges on 7 November 2026 at 05:10 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Tata Chemicals is a small-cap company in the Chemicals sector, with a market value of about ₹15,475 crore.

The stock last traded at ₹607.5, against a 52-week range of ₹570.1–₹876.4 (30.7% below the high).

Before this filing the shares had moved −0.1% over the month and −7.2% over three months. Average daily turnover over the last 20 sessions was about ₹121 crore.

Promoters held 37.98% at the end of Q1 FY27. Foreign institutions owned 12.07% and domestic institutions 21.12%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY263,7192529.89
Q2 FY263,877773.02
Q3 FY263,550-933.65
Q4 FY263,438-2,132-83.68
Q1 FY274,255-17-0.67

What history shows

This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Across 242 similar disclosures by other Chemicals companies, shares moved −1.1% on average the next day and −1.2% over five days; 38% of them rose the next day.

Market-wide, 10,949 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 7 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.